Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSS2500032	伊匹木单抗注射液	ipilimumab	Injection	Biological Products(2.2)	New Drug Application	2025-02-22		Xinda Biopharmaceutical Technology (Hangzhou) Co Ltd;Innovent Biologics (Suzhou) Co Ltd			view
JXSS2400092	伊匹木单抗注射液	ipilimumab	Injection	Biological Products(3.1)	Import Drug Application	2024-10-13		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd			view
JXSS2400093	伊匹木单抗注射液	ipilimumab	Injection	Biological Products(3.1)	Import Drug Application	2024-10-13		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd			view
JXSS2400056	伊匹木单抗注射液	ipilimumab	Injection	Biological Products(2.2)	Import Drug Application	2024-07-13		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd			view
JXSS2400055	伊匹木单抗注射液	ipilimumab	Injection	Biological Products(2.2)	Import Drug Application	2024-07-13		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd			view
JYSB2400093	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Supplementary Application	2024-04-24		Samsung Bioepis Co Ltd;Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company			view
JXSS2400038	伊匹木单抗注射液	ipilimumab	Injection	Biological Products(2.2)	Import Drug Application	2024-04-18		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd			view
JXSS2400040	伊匹木单抗注射液	ipilimumab	Injection	Biological Products(2.2)	Import Drug Application	2024-04-18		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd			view
CXSL2300420	IBI310	ipilimumab	Injection	Biological Products(2.2)	New Drug Application	2023-06-19		Innovent Biologics (Suzhou) Co Ltd			view
JYSB2300110	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Supplementary Application	2023-06-17		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company			view
JYSB2300080	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Supplementary Application	2023-04-29		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company			view
JXSB2101089	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Supplementary Application	2021-11-12		Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company			view
JXSB2101090	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Supplementary Application	2021-11-12		Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company			view
JYSB2101118	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Supplementary Application	2021-08-31		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company			view
JYSB2101119	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Supplementary Application	2021-08-31		Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company			view
CXSL2101073	IBI310	ipilimumab	Injection	Biological Products(2.2)	New Drug Application	2021-05-14		Innovent Biologics (Suzhou) Co Ltd			view
JXSB2101005	伊匹木单抗注射液	ipilimumab	Injection	Biological Products(2.2)	Supplementary Application	2021-04-28		Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company			view
JTS2100019	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Disposable Import Drug Application	2021-02-25	Bristol-Myers Squibb Holdings Pharma, Ltd.Liability Company	Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Pharma Eeig;Suzhou Xinda Biotechnology Co Ltd	Certificate Issued	2021-03-16	view
JTS2000062	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Disposable Import Drug Application	2021-01-01	苏州信达生物科技有限公司	Suzhou Xinda Biotechnology Co Ltd;Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	Pending Approval	2021-06-22	view
CXSL2000357	CS1002注射液	ipilimumab	Injection	Biological Products(2.2)	New Drug Application	2020-12-18	基石药业（苏州）有限公司	Cornerstone Pharmaceutical (Suzhou) Co Ltd	In Review	2020-12-16	view